EUVIMEDEUVIMED entdecken
Crossref

Regenerating hope: platelet-rich plasma as adjunct therapy for acute neuritis, recurrent nerve damage, and progressive disabilities in leprosy

Rohit Singh Chauhan, Sunil K. Gupta, Shivangi Rana, Kavita Swami, Farkhanda Sofi, Kritika Gupta

Leprosy Review · 01.06.2026 · 97 (2)

DOI: 10.47276/lr.97.2.2025146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Leprosy Review, online erschienen am 01.06.2026. Verfasst von Rohit Singh Chauhan und 5 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leprosy is a major cause of peripheral neuropathy, with patients experiencing acute or recurrent neuritis, progressive motor deficits, and pain, despite multidrug therapy and prolonged corticosteroid or NSAID use. Platelet-rich plasma (PRP), an autologous growth factor-rich concentrate, was assessed as an adjunctive regenerative treatment for leprosy-induced neuritis and disability, assessing changes in pain, neuritis grade, and motor function before and after therapy.​ Five patients with leprosy-related neuritis or neuropathy unresponsive to multidrug therapy, systemic steroids, and NSAIDs received perineural PRP prepared by the double-spin method. Ultrasound-guided PRP was injected around the affected ulnar, common peroneal, and posterior tibial nerves. Outcomes were evaluated using the Visual Analogue Scale (VAS) for pain and motor impairment, neuritis grade on palpation, and voluntary muscle testing (VMT) at baseline and day 5, with a 4-week follow-up.​ All treated nerves showed marked pain reduction, with very high baseline VAS scores decreasing to minimal or no pain by day 5 (about 80–60 to 0). Neuritis improved from Grade 2/3 to Grade 0 in most nerves within 5 days. VMT remained stable or showed early functional gains, with VAS-graded motor impairment improving from 70–50 to 40–20. No local or systemic complications occurred; recurrent neuritis did not recur in treated nerves, and analgesic and steroid requirements decreased.​ Ultrasound-guided perineural PRP appears safe and promising for leprosy-associated neuritis and neuropathy, enabling rapid pain relief, neuritis downgrading, early functional improvement, and reduced steroid exposure and warrants larger controlled trials to standardise protocols and confirm long-term efficacy.

Zitieren

APA

Chauhan, R. S., Gupta, S. K., Rana, S., Swami, K., Sofi, F., & Gupta, K. (2026). Regenerating hope: platelet-rich plasma as adjunct therapy for acute neuritis, recurrent nerve damage, and progressive disabilities in leprosy. Leprosy Review, 97(2). https://doi.org/10.47276/lr.97.2.2025146

Vancouver

Chauhan RS, Gupta SK, Rana S, Swami K, Sofi F, Gupta K. Regenerating hope: platelet-rich plasma as adjunct therapy for acute neuritis, recurrent nerve damage, and progressive disabilities in leprosy. Leprosy Review. 2026;97(2). doi:10.47276/lr.97.2.2025146

BibTeX
@article{Chauhan2026,
  author = {Chauhan, Rohit Singh and Gupta, Sunil K. and Rana, Shivangi and Swami, Kavita and Sofi, Farkhanda and Gupta, Kritika},
  title = {Regenerating hope: platelet-rich plasma as adjunct therapy for acute neuritis, recurrent nerve damage, and progressive disabilities in leprosy},
  journal = {Leprosy Review},
  year = {2026},
  volume = {97},
  number = {2},
  doi = {10.47276/lr.97.2.2025146}
}
Kostenlos starten →